Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

Related News New pill activates fat-burning ... Thyromimetic drugs can reduce levels of low-density lipoprotein (LDL) cholesterol and triglycerides while increasing high-density lipoprotein ...

Researchers from the University of Leicester, working with international collaborators, have unraveled a key mechanism by ...

Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while those who’ve had a heart attack or stroke are encouraged to drop LDL at least ...

Other groups are patients who have known heart disease and are on high dose statins and still can’t get their cholesterol down ... that you would see with this new therapy versus the patient ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

The drugs are listed in alphabetical order. Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to Humira. The injectable ...

Statins: For statins, the side effects can be surprising. Some people taking these medications have been found to gain weight ...

PfNCR1 acts like a transporter, he said, moving cholesterol around to keep ... This information could lead to a new approach of designing drugs to fight malaria more effectively.

PfNCR1 acts like a transporter, he said, moving cholesterol around to keep ... This information could lead to a new approach to designing drugs to fight malaria more effectively.

The U.S. government’s premier research body has made an important discovery that could help create new drugs to lower “bad” cholesterol, and hopefully prevent heart attacks and stroke.